CBCFF(CBCFF)
CBCFF
No analyst ratings available
No analyst price targets available for CBCFF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $370.13B | $385.90B | $397.79B | $405.83B | $415.97B |
| Low | $365.34B | $368.04B | $385.90B | $393.69B | $403.54B |
| High | $373.56B | $397.62B | $405.74B | $413.94B | $424.29B |
| EBITDA Avg | $50.70B | $52.86B | $54.49B | $55.59B | $56.98B |
| Low | $50.04B | $50.41B | $52.86B | $53.93B | $55.27B |
| High | $51.17B | $54.46B | $55.58B | $56.70B | $58.12B |
| EBIT Avg | $34.09B | $35.55B | $36.64B | $37.38B | $38.32B |
| Low | $33.65B | $33.90B | $35.55B | $36.26B | $37.17B |
| High | $34.41B | $36.63B | $37.37B | $38.13B | $39.08B |
| Net Income Avg | $18.16B | $20.00B | $21.01B | $24.78B | $25.81B |
| Low | $17.46B | $19.22B | $20.19B | $23.82B | $24.81B |
| High | $18.64B | $20.51B | $21.56B | $25.42B | $26.48B |
| EPS Avg | $146.71 | $161.51 | $169.71 | $200.15 | $208.49 |
| Low | $141.01 | $155.23 | $163.12 | $192.38 | $200.39 |
| High | $150.52 | $165.71 | $174.12 | $205.36 | $213.91 |
| Analysts (Rev / EPS) | 5 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $91.24B | $99.28B | $93.77B |
| Low | $90.30B | $98.11B | $92.73B |
| High | $92.33B | $100.44B | $94.87B |
| EBITDA Avg | $12.50B | $13.60B | $12.84B |
| Low | $12.37B | $13.44B | $12.70B |
| High | $12.65B | $13.76B | $13.00B |
| EBIT Avg | $8.40B | $9.14B | $8.64B |
| Low | $8.32B | $9.04B | $8.54B |
| High | $8.50B | $9.25B | $8.74B |
| Net Income Avg | $3.11B | $6.22B | $4.21B |
| Low | $3.07B | $6.13B | $4.15B |
| High | $3.16B | $6.31B | $4.27B |
| EPS Avg | $25.61 | $51.13 | $34.59 |
| Low | $25.24 | $50.40 | $34.09 |
| High | $26.00 | $51.92 | $35.12 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |